GE HEALTHCARE TECHNOLOGIES INC. FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $20.6B |
| Gross margin | 40.0% |
| Operating income | $2.8B |
| Net income | $2.1B |
| Diluted EPS | $4.55 |
| Cash & equivalents | $4.5B |
| Total assets | $36.9B |
| Long-term debt | $10.0B |
Key takeaway
GEHC reported full-year 2025 revenue of $20.6 billion with a 40% gross margin, translating into $2.76 billion of operating income and $2.08 billion of net income.
🔒 4 more takeaways in the full analysis
Beneath the surface
Net debt is smaller than headline debt suggests: against $10.0 billion total debt carrying amount, the company holds $4.49 billion cash, so net debt is roughly $5.5 billion rather than the full $10 billion long-term debt figure implies.
🔒 3 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for GEHC.
Read the full analysis free Free account · 5 full analyses included · no card required